Previous close | 81.18 |
Open | 80.89 |
Bid | 80.90 x 1000 |
Ask | 81.07 x 800 |
Day's range | 80.76 - 81.43 |
52-week range | 65.25 - 89.20 |
Volume | 9,004,702 |
Avg. volume | 9,025,303 |
Market cap | 204.882B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 17.88 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.60 (3.21%) |
Ex-dividend date | 14 Dec 2020 |
1y target est | N/A |
Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
US FDA Accepts for Priority Review the Biologics License Application for V114 for Use in Adults 18 Years of Age and Older
Merck to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference Call on February 4